preval
cancer
transmitt
diseas
persist
develop
new
advanc
therapi
remain
prioriti
medic
research
emerg
platform
treatment
ill
use
materi
form
via
peptid
assembl
bulk
materi
act
therapeut
higher
order
peptid
structur
defin
chemistri
capabl
cellular
target
recognit
intern
recent
design
effort
made
exploit
nanoscal
definit
materi
form
assembl
peptid
target
cancer
microbi
cell
function
vaccin
review
focus
assembl
peptid
materi
activ
particip
biolog
process
import
cancer
transmitt
diseas
exert
anticip
function
outcom
immun
system
primari
defens
toward
microbi
pathogen
foreign
substanc
compos
varieti
cell
recogn
destroy
pathogen
later
gain
immun
event
futur
encount
aid
immun
system
antibiot
vaccin
develop
treat
prevent
mani
ill
antibiot
assist
innat
immun
system
elimin
exist
bacteri
fungal
infect
altern
vaccin
exploit
adapt
immun
system
gain
immun
toward
diseas
transmit
virus
exampl
sever
vaccin
develop
success
prevent
communic
ill
includ
smallpox
diphtheria
measl
mump
polio
addit
vaccin
gardasil
approv
prevent
anal
cervic
vulvar
vagin
cancer
first
therapeut
cancer
vaccin
metastat
prostat
cancer
proveng
recent
fdaapprov
time
write
prostvac
phase
iii
clinic
trial
prostat
cancer
recent
emerg
antibiot
resist
microb
rapidli
mutat
virus
greatli
compromis
current
therapi
addit
ill
cancer
autoimmun
diseas
immun
system
fail
diseas
necessit
develop
altern
advanc
therapi
emerg
platform
treatment
cancer
transmitt
diseas
use
materi
form
via
peptid
assembl
bulk
materi
act
therapeut
last
sever
decad
peptid
materi
extens
develop
tissu
engin
scaffold
drug
deliveri
vehicl
materi
serv
passiv
role
intend
therapi
current
design
effort
made
exploit
nanoscal
definit
materi
form
assembl
peptid
target
cancer
microbi
cell
function
vaccin
materi
passiv
bystand
simpli
deliv
drug
serv
rebarb
cellular
attach
extracellular
matrix
elabor
activ
engag
intend
biolog
target
exert
anticip
function
outcom
review
focu
assembl
peptid
materi
activ
particip
biolog
process
import
cancer
transmitt
diseas
highlight
higher
order
structur
defin
chemistri
capabl
cellular
target
recognit
intern
repres
promis
lead
toward
treatment
human
ailment
use
selfassembl
peptid
build
block
materi
construct
rather
tradit
polym
peptid
gener
biocompat
biodegrad
provid
exquisit
select
bind
mani
weakli
immunogen
contrari
common
belief
seemingli
endless
array
structur
function
divers
design
peptid
monom
level
directli
translat
materi
form
selfassembl
figur
peptid
conveni
synthes
use
solid
phase
methodolog
take
advantag
vast
array
commerci
avail
natur
nonnatur
amino
acid
residu
peptid
elabor
function
conjug
peptid
biolog
activ
ligand
lipid
even
polym
use
synthet
bioconjug
strategi
nativ
chemic
ligat
oxim
chemistri
name
peptid
design
adopt
desir
structur
helic
sheet
serv
structur
build
block
higherord
structur
facial
block
amphiphil
engin
monomer
fold
structur
drive
selfassembl
yield
target
morpholog
common
materi
morpholog
realiz
peptid
assembl
includ
micel
nanoparticl
wormlik
micel
fibrillar
network
hybrid
network
compos
mixtur
peptid
polym
materi
side
chain
bioactiv
amino
acid
residu
peptid
sequenc
append
ligand
display
spatial
fidel
high
copi
number
one
bioactiv
moieti
display
multifunction
realiz
singl
materi
type
materi
shown
figur
possess
distinct
structur
mechan
properti
enabl
use
target
applic
exampl
fibrillar
network
form
hydrogel
easili
administ
topic
dermal
applic
discuss
review
hybrid
network
micel
nanoparticl
wormlik
micel
engin
facilit
cell
recognit
uptak
although
monomer
peptid
introduc
system
suffer
short
circul
halfliv
conform
denatur
induc
compon
serum
albumin
peptid
contain
within
assembl
enjoy
increas
halfliv
serum
conform
stabil
ideal
treatment
cancer
one
discrimin
cancer
healthi
tissu
repertoir
protein
express
surfac
tumor
cell
larg
similar
cell
compris
healthi
tissu
thu
allow
malign
cell
remain
indistinguish
immun
system
howev
protein
overexpress
mutat
exploit
cancer
specif
therapi
self
assembl
peptid
system
recent
design
target
bind
cell
membran
protein
present
cancer
cell
kopecek
et
al
figur
strategi
employ
coil
coil
peptid
target
membran
protein
surfac
burkitt
nonhodgkin
lymphoma
raji
bcell
one
coil
coil
cce
attach
fab
fragment
antibodi
wherea
peptid
cck
bound
hpma
n
methacrylamid
polym
antibodi
fragment
bind
bound
protein
remain
cell
surfac
expos
random
coil
cce
peptid
recognit
polymerbound
complementari
peptid
cck
result
coil
coil
assembl
two
peptid
accord
author
concomit
crosslink
receptor
lead
apoptosi
raji
bcell
premix
antibodyconjug
polymerconjug
induc
high
level
apoptosi
six
hour
incub
shown
figur
consecut
administr
two
compon
show
greater
level
apoptosi
hour
posit
control
crosslink
antibodi
gam
secondari
antibodi
shown
refer
importantli
higher
concentr
activ
assembl
peptid
system
demonstr
compar
apoptot
activ
posit
control
data
shown
upregul
enzym
extracellular
intracellular
also
common
within
tumor
outsid
cell
proteas
excret
breakdown
extracellular
matrix
allow
migrat
malign
cell
insid
cell
enzym
control
cell
signal
pathway
necessari
cell
prolifer
migrat
surviv
peptid
design
take
advantag
enzym
particularli
advantag
activ
depend
occurr
quantiti
enzym
present
allow
spatial
tempor
resolut
therapi
cancer
site
xu
et
al
develop
small
peptid
hydrogel
whose
selfassembl
trigger
endogen
esteras
within
hela
cervic
cancer
cell
propeptid
design
remain
solubl
outsid
cell
diffus
easili
cell
within
cellular
cytoplasm
propeptid
hydrolyz
liber
peptid
self
assembl
nanofib
fibril
format
within
cell
result
cell
death
figur
prolifer
cell
whose
level
enzym
express
low
affect
presenc
propeptid
demonstr
specif
peptid
design
preassembl
peptid
nanostructur
also
design
cancer
therapi
exampl
stupp
et
al
design
peptid
amphiphil
compos
bioactiv
peptid
conjug
alkyl
tail
promot
micellar
selfassembl
aqueou
solut
abil
assembl
target
tumor
reli
enhanc
permeabl
retent
epr
effect
found
develop
tumor
leaki
vasculatur
poor
lymphat
drainag
allow
nanostructur
order
nm
passiv
diffus
vessel
gap
accumul
local
tumor
site
one
particular
design
peptid
amphiphil
ch
ch
coa
g
klaklak
prepar
contain
cytotox
cation
peptid
sequenc
klaklak
append
palmit
alkyl
tail
peptid
portion
design
form
amphiphil
disrupt
cellular
mitochondri
membran
figur
peptid
amphiphil
assembl
nanofib
stabil
helic
conform
klak
sequenc
facilit
interact
membran
breast
cancer
cell
ultim
disrupt
membran
integr
caus
cell
death
data
figur
clearli
show
selfassembl
materi
respons
activ
peptid
portion
peptid
alon
presum
monomer
solut
activ
data
also
show
amphiphil
contain
peptid
correct
sequenc
activ
nice
demonstr
power
peptid
facilit
select
activ
materi
contain
peptid
micel
use
activ
engag
cellular
membran
facilit
intern
target
intracellular
protein
upregul
oncoprotein
downregul
tumor
suppressor
protein
cancer
cell
figur
exampl
inhibit
interact
wildtyp
protein
oncoprotein
counterpart
possibl
residu
sequenc
cell
imperm
thu
incap
reach
intend
target
tether
doubl
tail
lipid
onto
peptid
tirrel
et
al
prepar
peptid
amphiphil
assembl
micel
micel
capabl
enter
osteosarcoma
hela
cervic
cancer
breast
cancer
cell
studi
need
demonstr
target
peptid
amphiphil
transcript
factor
dna
bind
protein
also
intracellular
protein
often
upregul
cancer
cell
one
exampl
deregul
hox
protein
primari
solid
tumor
certain
hematolog
malign
caus
abnorm
gene
express
inhibit
possibl
target
bind
hox
cofactor
pbx
dna
use
antagonist
peptid
wypwmkkhh
facilit
intern
cell
hartgerink
et
al
design
peptid
amphiphil
ch
ch
conhwypwmkkhhrqikiwfqnrrmkwkk
peptid
antagonist
domain
append
palmit
alkyl
tail
cap
cell
penetr
sequenc
peptid
amphiphil
reduc
gene
express
sever
hox
gene
pancreat
cancer
cell
hour
shown
figur
capabl
inhibit
growth
cell
day
wherea
peptid
without
alkyl
chain
inhibit
cell
growth
control
peptid
compris
cell
penetr
portion
antagonist
portion
alon
palmityl
chain
deriv
show
effect
cell
growth
therefor
simpli
prepar
selfassembl
peptid
amphiphil
bioactiv
peptid
intracellular
activ
strongli
enhanc
exampl
selfassembl
materi
exert
action
preclud
necess
ad
drug
eventu
deliv
materi
elicit
activ
emerg
multidrug
resist
microb
challeng
immun
respons
current
therapi
also
drawn
attent
peptid
materi
antimicrobi
peptid
cation
amphiphil
peptid
display
nonspecif
broadspectrum
activ
toward
sever
microorgan
typic
monomer
solut
amphiphil
facial
sens
quit
differ
linear
block
amphiphil
typic
peptid
amphiphil
design
stupp
tirrel
hartgerink
fold
structur
antimicrobi
peptid
typic
helic
display
cationrich
face
distinct
oppos
hydrophob
face
unlik
small
molecul
antibiot
particular
cellular
target
cation
peptid
depend
sole
nonspecif
interact
neg
charg
bacteri
cell
surfac
polycation
face
peptid
facilit
initi
engag
cell
wall
bind
cell
surfac
peptid
insert
membran
occur
facilit
hydrophob
face
peptid
peptid
typic
assembl
form
pore
disrupt
membran
caus
cell
death
selfassoci
peptid
solut
prior
cell
engag
increas
potenc
cation
peptid
take
advantag
self
assembl
effect
yang
et
al
develop
nanoparticl
compris
argininerich
tat
peptid
shell
hydrophob
cholesterol
core
figur
nanoparticl
show
strong
antimicrobi
activ
sever
bacteria
includ
drugresist
strain
well
yeast
fungi
also
minim
inhibitori
concentr
nanoparticl
six
time
lower
peptid
portion
amphiphil
made
suggest
high
densiti
posit
charg
display
particl
lead
greater
membran
disrupt
compar
peptid
alon
similar
design
target
cancer
cell
xu
et
al
design
propeptid
taken
escherichia
coli
cleav
intracellular
phosphatas
cleav
peptid
self
assembl
nanofib
inhibit
bacteri
growth
group
design
hydrogel
scaffold
selfassembl
peptid
exhibit
inher
antibacteri
activ
twenti
amino
acid
peptid
undergo
trigger
intramolecular
fold
adopt
amphiphil
subsequ
selfassembl
rich
fibril
constitut
mechan
rigid
hydrogel
solvent
expos
cation
lysin
surfac
fibril
interact
neg
charg
bacteri
cell
surfac
ultim
compromis
membran
integr
figur
gel
show
bacteriocid
activ
toward
gramneg
e
coli
k
pneumonia
gramposit
epidermidi
pyrogen
drugsuscept
staphylococcu
aureu
system
materi
afford
selfassembl
activ
name
fibril
display
high
densiti
posit
charg
amino
acid
side
chain
surfac
subsequ
design
substitut
two
lysin
primari
sequenc
arginin
residu
result
peptid
name
peptid
selfassembl
form
hydrogel
activ
methicillinresist
aureu
mrsa
figur
show
experi
wherein
thin
strip
hydrogel
syring
deliv
bed
mrsa
grown
agar
surfac
livedead
assay
employ
confoc
microscopi
show
bacteria
beneath
deliv
hydrogel
dead
bacteri
growth
occur
outli
agar
expos
gel
figur
c
taken
togeth
peptid
materi
exampl
demonstr
higher
order
structur
defin
chemistri
result
self
assembl
offer
excel
bacteri
cell
target
activ
prevent
measur
vaccin
cancer
transmitt
diseas
also
explor
prime
immun
respons
prior
exposur
formid
ill
addit
vaccin
administ
therapeut
treat
exist
condit
case
previous
mention
proveng
often
effect
immunotherapi
complic
nonoptim
epitop
display
use
heterogen
adjuv
fail
induc
robust
antibodi
respons
use
selfassembl
peptid
antigen
hold
promis
sinc
synthet
peptid
prepar
precis
chemic
definit
optim
epitop
display
addit
selfassembl
structur
present
epitop
spatial
defin
multival
fashion
result
enhanc
biorecognit
immun
cell
collier
et
al
prepar
nanofib
selfassembl
peptid
display
b
cell
epitop
chicken
egg
ovalbumin
nanofib
abl
elicit
high
antibodi
titer
without
need
addit
adjuv
immun
respons
epitop
also
depend
coval
attach
selfassembl
fibril
compar
respons
observ
epitop
complet
freund
adjuv
observ
suggest
fibril
activ
particip
gener
respons
innoc
bystand
simpli
present
epitop
immun
cell
high
antigen
surfac
present
also
obtain
use
coil
coil
peptid
motif
synthet
viruslik
particl
deriv
robinson
et
al
lipopeptid
first
self
assembl
bundl
assembl
spheric
micel
cluster
lipid
chain
figur
surfac
coil
bundl
multipl
copi
desir
antigen
display
adjuvantfre
stimul
immun
system
burkhard
et
al
also
develop
nanoparticl
selfassembl
coil
coil
peptid
figur
epitop
malaria
sever
acut
respiratori
syndrom
sar
display
surfac
separ
nanoparticl
system
immun
respons
high
longliv
result
antibodi
display
high
avid
epitop
overal
selfassembl
peptid
novel
strategi
construct
simpl
chemic
defin
particl
potenti
vaccin
capabl
product
present
desir
antigen
preval
cancer
infecti
diseas
persist
develop
new
advanc
therapi
remain
prioriti
health
research
commun
novel
therapi
show
high
specif
enhanc
potenc
need
diseas
confound
immun
system
unrespons
current
avail
treatment
design
materi
via
peptid
assembl
potenti
impact
need
peptid
gener
grow
class
therapeut
product
market
clinic
trial
materi
made
exquisit
molecul
repres
novel
frontier
therapeut
design
said
exampl
provid
review
mainli
academ
natur
warrant
larg
amount
work
must
done
translat
clinic
small
molecul
cousin
mani
materi
fail
somewher
along
costli
arduou
path
develop
howev
materi
fail
therapi
sure
find
use
tool
understand
biolog
process
govern
diseas
therefor
design
novel
materi
potenti
significantli
impact
human
ailment
import
first
necessari
step
name
discoveri
bring
therapi
clinic
peptid
prepar
chemic
solid
support
function
via
ligat
chemistri
peptid
ligand
lipid
polym
impart
function
control
fold
self
assembl
selfassembl
materi
engin
control
display
biofunction
enabl
target
applic
assembl
drawn
scale
exampl
peptidebas
materi
design
interact
cancer
cell
extracellularli
intracellularli
counterclockwis
cell
membran
protein
orang
bound
portion
white
antibodycc
conjug
cce
red
form
coil
coil
cck
peptid
blue
coval
attach
hmpa
polym
green
propeptid
blue
leav
group
yellow
enter
easili
cell
hydrolyz
enzym
purpl
liber
peptid
self
assembl
nanofib
wormlik
micel
nanofib
blue
red
form
peptid
amphiphil
disrupt
lipid
cellular
membran
interact
protein
blue
oncoprotein
counterpart
green
inhibit
micel
form
peptid
amphiphil
contain
antagonist
peptid
interact
hox
orang
cofactor
pbx
yellow
dna
inhibit
micel
form
peptid
amphiphil
contain
antagonist
peptid
wypwmkkhh
b
timedepend
apoptosi
burkitt
lymphoma
raji
b
cell
exposur
treatment
cce
alon
cck
p
alon
antibodi
gam
secondari
antibodi
premixtur
cce
cck
p
consecut
addit
cce
follow
cck
